Company  Sector  Country
ALPHAVALUE SEARCH
 
     
 
Forgotten password ? 		LOG IN

Synthes

  SYST VX

Med Tech
 /  Switzerland 
Another record year
Updates
30/07/2010Earnings/sales releases
Synthes reported strong H1 results to ...
29/04/2010Earnings/sales releases
Q1 revenues to end March. Revenues...
17/02/2010Earnings/sales releases
Synthes reported strong 2009 results. ...
21/10/2009Earnings/sales releases
Synthes published revenue figures for ...
03/08/2009Latest
Revenues in the first half 2009 ending...
23/02/2009Latest
Q4 revenues increased 4.4% to USD8...
Summary Key Data
Updated :
  12/08A
12/09A
12/10E
12/11E
12/12E
AlphaValue P/E (x) 21.7 18.4
Dividend yield (%) 0.77 1.09
EV/EBITDA (x) 11.3 9.14
AlphaValue EPS ($) 6.06 6.46
Dividend (CHF) 1.10 1.35
Sales ($M) 3,193 3,395
EBITDA ($M) 1,340 1,427
Attributable net profit ($M) 719 767
ROE (after tax) (%) 16.1 14.7
ROCE (%) 16.1 16.5
Gearing (%) -12.0 -20.2
Next Div. Indic CHF 1.35 payment
Target
Price (CHF) 120
Target Price (CHF)
Market Cap (CHFM) 14,277
Perf. 1W: 6.18 %
Perf. 1M: -3.61 %
Perf. 3M: 0.33 %
Perf Ytd: -11.1 %
Rating
  • Strong momentum corresponding to a continuous and overall positive moving average trend confirmed by volumes
  • Relatively good momentum corresponding to a positively-oriented moving average, but offset by an overbought pattern or lack of confirmation from volumes
  • Relatively unfavorable momentum with a neutral or negative moving average trend, but offset by an oversold pattern or lack of confirmation from volumes
  • Strongly negative momentum corresponding to a continuous and overall negative moving average trend confirmed by volumes
VALUE
TEST IT !
RISK
TEST IT !
GOVERNANCE
TEST IT !
RANKING
Best
Worst
Businesses & Trends
Synthes, with headquarters in Delaware, is a world-leading medical device company. In 1999 Stratec Medical (management buyout... Read More
Money Making
The company benefits from its innovative and expensive product range. Product growth is mainly driven by the ageing population a... Read More
Valuation
The company has a proven and successful business model and is debt free. In our DCF model we expect top-line growth of 6% whi... Read More
Analyst: Heinz Steffen
Concepts
Business concepts
  • R&D driven
  • Barrier to entry
  • Family controls/influence
  • Structural growth
  • Margins on paying third ...
Investment Concepts
  • Quasi oligopoly
  • Golden ageing
  • Margin expansion
Story Trigger
  • Order intake shift
© 2010, AlphaValue All rights reserved. This publication is strictly for subscriber’s own, non-commercial, internal use. No part of it may be reproduced, resold, stored or transmitted in any printed, electronic or other form, or used for generating or marketing any printed or electronic publication, service or product.
About AlphaValue | Help / FAQ | Product | Ethical charter | Contact Us |Legal Mentions